Literature DB >> 15084985

Role of the phosphatidylinositol 3'-kinase-Akt signal pathway in the proliferation of human pancreatic ductal carcinoma cell lines.

Ami Takeda1, Mitsuhiko Osaki, Keiko Adachi, Soichiro Honjo, Hisao Ito.   

Abstract

: Phosphatidylinositol 3'-kinase (PI3K) and Akt mediate survival signals and allow the cells to escape apoptosis in various human cancers. We postulated that LY294002, a PI3K inhibitor, might inactivate Akt, consequently inhibiting cell proliferation in 3 human pancreatic ductal carcinoma cell lines, PSN-1, PANC-1, and KP-4. LY294002 (50 micromol/L) caused a decrease in phosphorylated Akt and inhibition of cell proliferation in a time-dependent manner, but there was no obvious induction of apoptosis. Flow cytometric analysis revealed that pancreatic cancer cells treated with 50 micromol/L LY294002 underwent G1 arrest, which was associated with dephosphorylation of the ppRB protein, a decrease in the protein expression of cyclin D and E, and their activating partners Cdk2, 4, and 6 with simultaneous accumulation of P27/Kip1. Our data indicate that P27/Kip1 accumulation by Akt inactivation could induce cell cycle arrest in the G1 phase and suggest that the PI3K-Akt pathway plays an important role in cell proliferation in human pancreatic ductal carcinoma cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15084985     DOI: 10.1097/00006676-200404000-00026

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  19 in total

1.  RNAi knockdown of PIK3CA preferentially inhibits invasion of mutant PIK3CA cells.

Authors:  Xin-Ke Zhou; Sheng-Song Tang; Gao Yi; Min Hou; Jin-Hui Chen; Bo Yang; Ji-Fang Liu; Zhi-Min He
Journal:  World J Gastroenterol       Date:  2011-08-28       Impact factor: 5.742

2.  Apoptosis mechanisms of human gastric cancer cell line MKN-45 infected with human mutant p27.

Authors:  Jin-Shui Zhu; Long Wang; Guo-Qiang Cheng; Qin Li; Zu-Ming Zhu; Li Zhu
Journal:  World J Gastroenterol       Date:  2005-12-21       Impact factor: 5.742

3.  AGE/RAGE/Akt pathway contributes to prostate cancer cell proliferation by promoting Rb phosphorylation and degradation.

Authors:  Ji-Ming Bao; Min-Yi He; Ya-Wei Liu; Yong-Jie Lu; Ying-Qia Hong; Hai-Hua Luo; Zhong-Lu Ren; Shan-Chao Zhao; Yong Jiang
Journal:  Am J Cancer Res       Date:  2015-04-15       Impact factor: 6.166

4.  Insulin-like growth factor-I receptor in proliferation and motility of pancreatic cancer.

Authors:  Minoru Tomizawa; Fuminobu Shinozaki; Takao Sugiyama; Shigenori Yamamoto; Makoto Sueishi; Takanobu Yoshida
Journal:  World J Gastroenterol       Date:  2010-04-21       Impact factor: 5.742

5.  Combinatorial therapies improve the therapeutic efficacy of nanoliposomal ceramide for pancreatic cancer.

Authors:  Yixing Jiang; Nicole A DiVittore; James M Kaiser; Sriram S Shanmugavelandy; Jennifer L Fritz; Yasser Heakal; Hephzibah Rani S Tagaram; Hua Cheng; Myles C Cabot; Kevin F Staveley-O'Carroll; Melissa A Tran; Todd E Fox; Brian M Barth; Mark Kester
Journal:  Cancer Biol Ther       Date:  2011-10-01       Impact factor: 4.742

Review 6.  Current update on established and novel biomarkers in salivary gland carcinoma pathology and the molecular pathways involved.

Authors:  Markus Stenner; J Peter Klussmann
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-12-04       Impact factor: 2.503

7.  Early effects of lasonolide a on pancreatic cancer cells.

Authors:  Richard A Isbrucker; Esther A Guzmán; Tara P Pitts; Amy E Wright
Journal:  J Pharmacol Exp Ther       Date:  2009-08-19       Impact factor: 4.030

8.  Curcumin analogues exhibit enhanced growth suppressive activity in human pancreatic cancer cells.

Authors:  Lauren Friedman; Li Lin; Sarah Ball; Tanios Bekaii-Saab; James Fuchs; Pui-Kai Li; Chenglong Li; Jiayuh Lin
Journal:  Anticancer Drugs       Date:  2009-07       Impact factor: 2.248

9.  Insulin-like growth factor binding protein-5 influences pancreatic cancer cell growth.

Authors:  Sarah K Johnson; Randy S Haun
Journal:  World J Gastroenterol       Date:  2009-07-21       Impact factor: 5.742

10.  Simultaneous blockade of AP-1 and phosphatidylinositol 3-kinase pathway in non-small cell lung cancer cells.

Authors:  J Kikuchi; I Kinoshita; Y Shimizu; S Oizumi; M Nishimura; M J Birrer; H Dosaka-Akita
Journal:  Br J Cancer       Date:  2008-11-18       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.